Ligand Pharmaceuticals
LGND
#4143
Rank
NZ$3.83 B
Marketcap
$202.71
Share price
0.61%
Change (1 day)
80.15%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2024 (TTM): NZ$0.10 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.15 Billion. In 2023 the company made an earning of NZ$0.11 Billion a decrease over its 2022 earnings that were of NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.10 B-8.97%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$29.85 M-97.97%
2019 NZ$1.47 B275.62%
2018 NZ$0.39 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$77.89 M55.41%
2015 NZ$50.12 M36.87%
2014 NZ$36.62 M29.59%
2013 NZ$28.25 M1309.35%
2012 NZ$2 M-43.97%
2011 NZ$3.57 M-113.19%
2010 -NZ$27.14 Million59.86%
2009 -NZ$16.98 Million-61.33%
2008 -NZ$43.9 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$88.29 Million81.27%
2005 -NZ$48.71 Million
2003 -NZ$33.91 Million-20.6%
2002 -NZ$42.71 Million4.38%
2001 -NZ$40.92 Million-48.83%
2000 -NZ$79.95 Million-19.74%
1999 -NZ$99.62 Million-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$54.29 Million-5.83%
1996 -NZ$57.65 Million136.23%
1995 -NZ$24.41 Million-33.97%
1994 -NZ$36.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$8.27 B 7,558.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.11 Billion-201.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.37 B 6,726.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$26.47 B 24,407.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.27 B 11,264.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.94 B 16,514.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.17 Billion-11,360.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.29 B 171.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.52 B 30,008.35%๐Ÿ‡บ๐Ÿ‡ธ USA